ID   FH11
AC   CVCL_E597
SY   Extract 142; Extract 203; Extract 498
DR   dbMHC; 48784
DR   IHW; IHW09385
DR   IPD-IMGT/HLA; 25994
DR   Wikidata; Q54834799
RX   PubMed=30844424;
WW   http://pathology.ucla.edu/workfiles/353cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01,29:02; B*07:02:01,44:04; C*07:02,16:01; DPB1*02:01:02,11:01:01; DQB1*03:01,05:01; DRB1*01:01,11:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=25994).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//